Daewoong Pharmaceutical Co., Ltd (KRX: 069620)
South Korea
· Delayed Price · Currency is KRW 138,500
+6,700 (5.08%)
Feb 4, 2025, 9:00 AM KST
Daewoong Pharmaceutical Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 3, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 1,610,878 | 1,343,932 | 1,754,469 | 1,638,243 | 1,775,845 | 1,419,120 | Upgrade
|
| Market Cap Growth | 22.61% | -23.40% | 7.09% | -7.75% | 25.14% | -27.06% | Upgrade
|
| Enterprise Value | 2,255,525 | 1,735,899 | 2,148,696 | 2,022,062 | 2,205,804 | 1,750,747 | Upgrade
|
| Last Close Price | 140000.00 | 116232.55 | 156907.02 | 145950.84 | 162053.57 | 134520.20 | Upgrade
|
| PE Ratio | 15.55 | 11.04 | 41.54 | 66.85 | 139.24 | 64.49 | Upgrade
|
| Forward PE | 15.95 | 41.35 | 41.35 | 41.35 | 41.35 | 44.77 | Upgrade
|
| PS Ratio | 1.14 | 0.98 | 1.37 | 1.42 | 1.68 | 1.27 | Upgrade
|
| PB Ratio | 1.97 | 1.47 | 2.37 | 2.35 | 2.55 | 2.23 | Upgrade
|
| P/TBV Ratio | 3.26 | 2.15 | 3.79 | 3.83 | 4.26 | 3.73 | Upgrade
|
| P/FCF Ratio | - | 50.39 | 33.11 | 150.21 | 23.84 | 40.22 | Upgrade
|
| P/OCF Ratio | 37.48 | 9.88 | 14.84 | 40.96 | 17.59 | 24.64 | Upgrade
|
| PEG Ratio | 1.19 | 0.24 | 0.24 | 0.24 | 0.24 | 0.26 | Upgrade
|
| EV/Sales Ratio | 1.59 | 1.26 | 1.68 | 1.75 | 2.09 | 1.57 | Upgrade
|
| EV/EBITDA Ratio | 10.00 | 10.53 | 15.86 | 15.60 | 38.12 | 20.63 | Upgrade
|
| EV/EBIT Ratio | 12.67 | 14.33 | 22.43 | 22.79 | 129.91 | 39.18 | Upgrade
|
| EV/FCF Ratio | -19.01 | 65.09 | 40.55 | 185.40 | 29.61 | 49.62 | Upgrade
|
| Debt / Equity Ratio | 0.65 | 0.48 | 0.60 | 0.64 | 0.64 | 0.62 | Upgrade
|
| Debt / EBITDA Ratio | 3.36 | 2.68 | 3.30 | 3.44 | 7.70 | 4.63 | Upgrade
|
| Debt / FCF Ratio | - | 16.54 | 8.43 | 40.87 | 5.98 | 11.14 | Upgrade
|
| Asset Turnover | 0.78 | 0.83 | 0.86 | 0.83 | 0.81 | 0.91 | Upgrade
|
| Inventory Turnover | 2.89 | 3.06 | 3.39 | 3.54 | 3.47 | 3.47 | Upgrade
|
| Quick Ratio | 0.56 | 0.47 | 0.68 | 0.72 | 0.99 | 1.28 | Upgrade
|
| Current Ratio | 1.07 | 0.86 | 1.16 | 1.13 | 1.62 | 2.01 | Upgrade
|
| Return on Equity (ROE) | 10.75% | 14.51% | 5.44% | 4.32% | 3.63% | 4.64% | Upgrade
|
| Return on Assets (ROA) | 4.70% | 4.54% | 4.03% | 3.99% | 0.81% | 2.28% | Upgrade
|
| Return on Capital (ROIC) | 6.01% | 5.96% | 5.14% | 4.85% | 0.98% | 2.76% | Upgrade
|
| Return on Capital Employed (ROCE) | 9.86% | 10.98% | 8.78% | 9.34% | 1.63% | 4.54% | Upgrade
|
| Earnings Yield | 6.43% | 9.06% | 2.41% | 1.50% | 0.72% | 1.55% | Upgrade
|
| FCF Yield | -7.36% | 1.98% | 3.02% | 0.67% | 4.19% | 2.49% | Upgrade
|
| Dividend Yield | 0.43% | 0.52% | - | - | - | - | Upgrade
|
| Payout Ratio | 7.46% | 5.98% | 19.10% | 26.35% | 48.56% | 28.14% | Upgrade
|
| Buyback Yield / Dilution | -1.68% | -3.21% | -0.59% | -3.21% | -3.31% | - | Upgrade
|
| Total Shareholder Return | -1.25% | -2.69% | -0.59% | -3.21% | -3.31% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.